Blackcrane Capital, LLC
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Mar 31, 2022, never from the firm's own description.
Over time 9 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share against every 13F filer's combined book at 20% or less, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
6 tracked positions · as of Mar 31, 2022 · Δ vs Dec 31, 2021Portfolio Trend
Sector Breakdown
As of Mar 31, 2022| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 39.9% | $4,419,072 |
| Financial Services | 32.0% | $3,545,303 |
| Healthcare | 28.0% | $3,097,493 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedTrimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PROF | Profound Medical Corp. | −746,351 | 255,292 | $2,297,628 | |
| RCEL | AVITA Medical, Inc. | −411,547 | 43,324 | $367,387 | |
| WIX | Wix.com Ltd. | −38,835 | 21,643 | $2,260,827 | |
| NICE | NICE Ltd. | −31,783 | 9,855 | $2,158,245 | |
| HDB | Hdfc Bank Ltd | −12,823 | 57,807 | $3,545,303 | |
| TAK | Takeda Pharmaceutical Co Ltd | −937 | 30,201 | $432,478 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| HDB |
Hdfc Bank Ltd
Financial Services
|
Reduced | 57,807 | $3,545,303 | 32.05% | |
| PROF |
Profound Medical Corp.
Healthcare
|
Reduced | 255,292 | $2,297,628 | 20.77% | |
| WIX |
Wix.com Ltd.
Technology
|
Reduced | 21,643 | $2,260,827 | 20.44% | |
| NICE |
NICE Ltd.
Technology
|
Reduced | 9,855 | $2,158,245 | 19.51% | |
| TAK |
Takeda Pharmaceutical Co Ltd
Healthcare
|
Reduced | 30,201 | $432,478 | 3.91% | |
| RCEL |
AVITA Medical, Inc.
Healthcare
|
Reduced | 43,324 | $367,387 | 3.32% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.